Hierarchical composite endpoints (HCEs) are increasingly being used in infectious diseases research. In this review aimed at educating the clinical reader,

Editors of CMI Comms, Josh Davis, Erin McCreary and Emily McDonald...

This episode of Communicable takes on a special format where editors of...

Podcast Episode · Breakpoints · 05/04/2025 · 1h 11m

More than hundred years ago a series of experiments demonstrated that increased strechting of heart muscles (through higher venous return) increased stroke volume (cardiac output). But not endlessly, ...

“Selective digestive tract decontamination” (SDD) refers to the use of antibiotics to decrease bacterial load in the gut with the intention of reducing the risk of pneumonia (from microaspiration) and...

For those who do hospital-based patient care, the significance of Staphylococcus aureus bacteremia (SAB) cannot be overstated. It’s one of the most frequent reasons for infectious disease consultation...

A major new clinical trial, the Streptococcal Adaptive Platform (STRAP), has received $5 million in funding from the Australian Government’s Medical Research Future Fund (MRFF) to improve treatment for life-threatening streptococcal infections across all age groups. Lead by researchers and clinicians from the Doherty Institute, Murdoch Children's Research Institute (MCRI), and other national and international partners.